FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3088573611> ?p ?o ?g. }

• W3088573611 endingPage "1038.e6" @default.
• W3088573611 startingPage "1038.e1" @default.
• W3088573611 abstract "The aim of this study was to evaluate acquired drug resistance in Italy in the 2009-2018 period.We analysed 3094 patients from the Italian ARCA database who had failed antiretroviral treatment and who had received a genotypic test after 6 months of treatment. Drug resistance mutations were identified using International AIDS Society (IAS)-USA tables and the Stanford HIVdb algorithm. The global burden of acquired resistance was calculated among all subjects with antiretroviral failure. Time trends and correlates of resistance were analysed using standard statistical tests.Patients of non-European origin and non-B subtypes increased significantly from 11.5% (103/896) to 19.2% (33/172) and from 13.1% (141/1079) to 23.8% (53/223), respectively, over time. Overall, 14.5% (448/3094), 12.1% (374/3094) and 37.8% (1169/3094) of patients failed first, second and later lines, respectively. According to both IAS and HIVdb, in the study period resistance to any class, nucleoside reverse inhibitor, non-nucleoside reverse inhibitor, and protease inhibitors (PIs) declined significantly. Integrase strand transfer inhibitor (INSTI) resistance declined significantly from 31% (36/116) to 20.8% (41/197) according to HIVdb but not to IAS. Divergent data were highlighted regarding the proportion of non-European patients carrying any, PI and INSTI resistance using IAS tables compared with the Stanford HIVdb algorithm, as the former failed to detect a decrease in resistance while the latter indicates a reduction of 1.6-, 5- and 1.8-fold resistance for such drug classes. In the multivariate analysis, the risk of resistance increased in patients with a larger number of treatment lines and higher viraemia and decreased in those starting therapy in the last biennium of the study.A marked reduction in drug resistance was observed over 10 years, compatible with higher genetic barrier and potency of new antiretrovirals. Nonetheless, concerns remain for subjects with non-B subtypes when using mutation lists instead of interpretation systems because of the extensive polymorphism of the protease region." @default.
• W3088573611 created "2020-10-01" @default.
• W3088573611 creator A5002495981 @default.
• W3088573611 creator A5021259835 @default.
• W3088573611 creator A5023984688 @default.
• W3088573611 creator A5027991189 @default.
• W3088573611 creator A5032729011 @default.
• W3088573611 creator A5034013887 @default.
• W3088573611 creator A5041785868 @default.
• W3088573611 creator A5052006950 @default.
• W3088573611 creator A5062393418 @default.
• W3088573611 creator A5068011395 @default.
• W3088573611 creator A5074577164 @default.
• W3088573611 creator A5085354537 @default.
• W3088573611 creator A5085992339 @default.
• W3088573611 creator A5089618460 @default.
• W3088573611 date "2021-07-01" @default.
• W3088573611 modified "2023-10-14" @default.
• W3088573611 title "Marked decrease in acquired resistance to antiretrovirals in latest years in Italy" @default.
• W3088573611 cites W1499520752 @default.
• W3088573611 cites W1923608185 @default.
• W3088573611 cites W1990828872 @default.
• W3088573611 cites W2020780549 @default.
• W3088573611 cites W2030038632 @default.
• W3088573611 cites W2046134251 @default.
• W3088573611 cites W2050621055 @default.
• W3088573611 cites W2066141181 @default.
• W3088573611 cites W2076696614 @default.
• W3088573611 cites W2110249458 @default.
• W3088573611 cites W2129294673 @default.
• W3088573611 cites W2140227530 @default.
• W3088573611 cites W2158670905 @default.
• W3088573611 cites W2339873888 @default.
• W3088573611 cites W2604690888 @default.
• W3088573611 cites W2714685582 @default.
• W3088573611 cites W2739715939 @default.
• W3088573611 cites W2884986477 @default.
• W3088573611 cites W2921757107 @default.
• W3088573611 cites W2969479109 @default.
• W3088573611 cites W4207048504 @default.
• W3088573611 cites W4230491740 @default.
• W3088573611 cites W4234790260 @default.
• W3088573611 doi "https://doi.org/10.1016/j.cmi.2020.09.028" @default.
• W3088573611 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/32979570" @default.
• W3088573611 hasPublicationYear "2021" @default.
• W3088573611 type Work @default.
• W3088573611 sameAs 3088573611 @default.
• W3088573611 citedByCount "0" @default.
• W3088573611 crossrefType "journal-article" @default.
• W3088573611 hasAuthorship W3088573611A5002495981 @default.
• W3088573611 hasAuthorship W3088573611A5021259835 @default.
• W3088573611 hasAuthorship W3088573611A5023984688 @default.
• W3088573611 hasAuthorship W3088573611A5027991189 @default.
• W3088573611 hasAuthorship W3088573611A5032729011 @default.
• W3088573611 hasAuthorship W3088573611A5034013887 @default.
• W3088573611 hasAuthorship W3088573611A5041785868 @default.
• W3088573611 hasAuthorship W3088573611A5052006950 @default.
• W3088573611 hasAuthorship W3088573611A5062393418 @default.
• W3088573611 hasAuthorship W3088573611A5068011395 @default.
• W3088573611 hasAuthorship W3088573611A5074577164 @default.
• W3088573611 hasAuthorship W3088573611A5085354537 @default.
• W3088573611 hasAuthorship W3088573611A5085992339 @default.
• W3088573611 hasAuthorship W3088573611A5089618460 @default.
• W3088573611 hasBestOaLocation W30885736111 @default.
• W3088573611 hasConcept C104317684 @default.
• W3088573611 hasConcept C114851261 @default.
• W3088573611 hasConcept C126322002 @default.
• W3088573611 hasConcept C135763542 @default.
• W3088573611 hasConcept C142462285 @default.
• W3088573611 hasConcept C14430832 @default.
• W3088573611 hasConcept C159047783 @default.
• W3088573611 hasConcept C18903297 @default.
• W3088573611 hasConcept C2777302000 @default.
• W3088573611 hasConcept C2781143361 @default.
• W3088573611 hasConcept C2993143319 @default.
• W3088573611 hasConcept C3013748606 @default.
• W3088573611 hasConcept C54355233 @default.
• W3088573611 hasConcept C57473165 @default.
• W3088573611 hasConcept C71924100 @default.
• W3088573611 hasConcept C86803240 @default.
• W3088573611 hasConceptScore W3088573611C104317684 @default.
• W3088573611 hasConceptScore W3088573611C114851261 @default.
• W3088573611 hasConceptScore W3088573611C126322002 @default.
• W3088573611 hasConceptScore W3088573611C135763542 @default.
• W3088573611 hasConceptScore W3088573611C142462285 @default.
• W3088573611 hasConceptScore W3088573611C14430832 @default.
• W3088573611 hasConceptScore W3088573611C159047783 @default.
• W3088573611 hasConceptScore W3088573611C18903297 @default.
• W3088573611 hasConceptScore W3088573611C2777302000 @default.
• W3088573611 hasConceptScore W3088573611C2781143361 @default.
• W3088573611 hasConceptScore W3088573611C2993143319 @default.
• W3088573611 hasConceptScore W3088573611C3013748606 @default.
• W3088573611 hasConceptScore W3088573611C54355233 @default.
• W3088573611 hasConceptScore W3088573611C57473165 @default.
• W3088573611 hasConceptScore W3088573611C71924100 @default.
• W3088573611 hasConceptScore W3088573611C86803240 @default.
• W3088573611 hasIssue "7" @default.
• W3088573611 hasLocation W30885736111 @default.

• next